Fabry’s disease (FD) is an X-linked recessive disorder. The onset of clinical symptoms usually occurs during childhood or adolescence, but may be as late as the third or fourth decade. Early manifestations consist of episodic pain in the extremities and a teleangiectatic scaly maculopapular rash called angiokeratoma corporis diffusum. The angiokeratomas usually appear between the ages of 7 and 10 years and are dark red to black nonblanching macules and papules that range in size from punctate to 4 mm in diameter. They increase in number with time. They have a predilection for the genitals, the upper thighs and the lower trunk, and spare the face, scalp, palms and soles.
KeywordsBurning Fatigue High Performance Liquid Chromatography Ischemia Dementia
Unable to display preview. Download preview PDF.
- Kornreich R, Bishop DF, Desnick RJ (1990) a-galactosidase A gene rearrangements causing Fabry disease. J Biol Chem 265: 9319–9326Google Scholar
- Morgan SH, Rudge P, Smith SJM, Bronstein AM, Kendall BE, Holly E, Young EP, Crawfurd MA, Bannister R (1990) The neurological complications of Anderson-Fabry disease (agalactosidase A deficiency): investigation of symptomatic and presymptomatic patients. Q J Med New Ser 75: 491–504Google Scholar
- Moumdjian R, Tampieri D, Melanson D, Ethier R (1989) Anderson-Fabry disease: a case report with MR, CT and cerebral angiography. AJNR 10: 569 - S70Google Scholar
- Nelis GF, Jacobs GJA (1989) anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum ( Fabry-Andersons disease ). Dig Dis Sci 34: 17981800Google Scholar
- Paller AS (1987) Metabolic disorders characterized by angiokeratomas and neurologic dysfunction. Neurol Clin 5: 441446Google Scholar
- Thomas PK (1988) Inherited neuropathies related to disorders of lipid metabolism. In: DiDonato S (ed) Advances in neurology, molecular genetics of neurological and neuromuscular disease. Raven, New York, pp 133–144Google Scholar